Endonasal phototherapy with Rhinolight® for the treatment of allergic rhinitis

Expert Review of Medical Devices

Volumn 7, Issue 1, 2010, Pages 21-26

  Brehmer, Detlef ^a  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

Author keywords

Allergic rhinitis; Phototherapy; Rhinolight ; Ultraviolet therapy

Indexed keywords

ANTIALLERGIC AGENT; ANTIHISTAMINIC AGENT; FEXOFENADINE; IMMUNOGLOBULIN E; STEROID;

ALLERGIC RHINITIS; ATOPIC DERMATITIS; CLINICAL EFFECTIVENESS; COST EFFECTIVENESS ANALYSIS; HAY FEVER; HEALTH CARE COST; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOTHERAPY; NOSE CAVITY; PATIENT SAFETY; PHOTOTHERAPY; QUALITY OF LIFE; RADIATION EQUIPMENT; RAGWEED POLLEN; REVIEW; SKIN DISEASE; THERAPY EFFECT; TREATMENT DURATION; ULTRAVIOLET A RADIATION; ULTRAVIOLET B RADIATION; DOUBLE BLIND PROCEDURE; INSTRUMENTATION; METHODOLOGY; PERENNIAL RHINITIS; RANDOMIZED CONTROLLED TRIAL; ULTRAVIOLET RADIATION;

DERMATITIS, ATOPIC; DOUBLE-BLIND METHOD; HUMANS; IMMUNOSUPPRESSION; NASAL CAVITY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RHINITIS, ALLERGIC, PERENNIAL; RHINITIS, ALLERGIC, SEASONAL; ULTRAVIOLET RAYS; ULTRAVIOLET THERAPY;

EID: 77449134439     PISSN: 17434440     EISSN: 17452422     Source Type: Journal    
DOI: 10.1586/erd.09.56     Document Type: Review

References (49)

1. Meltzer EO, Nathan R, Derebery J et al. Sleep, quality of life, and productivity impact of nasal symptoms in the United States: fndings from the Burden of Rhinitis in America survey. Allergy Asthma Proc. 30(3), 244-254 (2009).
2. Bousquet J, Khaltaev N, Cruz AA et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organisation, GALEN and AllerGEN. Allergy 63(Suppl. 86), 8-160 (2008). (Pubitemid 351357811)
3. Gupta R, Sheikh A, Strachan DP, Anderson HR. Burden of allergic disease in the UK: secondary analyses of national databases. Clin. Exp. Allergy 34(4), 520-526 (2004). (Pubitemid 38534881)
4. Bunnag C, Jareoncharsri P, Tantilipikorn P, Vichyanond P, Pawankar R. Epidemiology and current status of allergic rhinitis and asthma in Thailand-ARIA Asia-Pacifc Workshop report. Asian Pac. J. Allergy Immunol. 27(1), 79-86 (2009).
5. Wilson DR, Lima MT, Durham SR. Sublingual immunotherapy for allergic rhinitis: systematic review and meta-analysis. Allergy 60(1), 4-12 (2005).
6. Calderon MA, Alves B, Jacobson M, Hurwitz B, Sheikh A, Durham S. Allergen injection immunotherapy for seasonal allergic rhinitis. Cochrane Database Syst. Rev. 1, CD001936 (2007). (Pubitemid 46527840)
7. Varney VA, Tabbah K, Mavroleon G, Frew AJ. Usefulness of specifc immunotherapy in patients with severe perennial allergic rhinitis induced by house dust mite: a double-blind, randomized, placebo-controlled trial. Clin. Exp. Allergy 33(8), 1076-1082 (2003). (Pubitemid 36976234)
8. Ewbank PA, Murray J, Sanders K, Curran-Everett D, Dreskin S, Nelson HS. A double-blind, placebo-controlled immunotherapy dose-response study with standardized cat extract. J. Allergy Clin. Immunol. 111(1), 155-161 (2003). (Pubitemid 36143307)
9. The Authority of the House of Lords. Allergy, Volume 1: Report. The Stationary Offce Limited, London, UK (2007).
10. + T cells by grass pollen immunotherapy. J. Allergy Clin. Immunol. 111(6), 1255-1261 (2003). (Pubitemid 36683679)
11. Akdis CA, Blaser K. IL-10-induced anergy in peripheral T cell and reactivation by microenvironmental cytokines: two key steps in specifc immunotherapy. FASEB J. 13(6), 603-609 (1999). (Pubitemid 29156392)
12. Jutel M, Pichler WJ, Skrbic D, Urwyler A, Dahinden C, Müller UR. Bee venom immunotherapy results in decrease of IL-4 and IL-5 and increase of IFN-g-secretion in specifc allergen-stimulated T cell cultures. J. Immunol. 154(8), 4187-4194 (1995).
13. Akdis CA, Akdis M. Mechanisms and treatment of allergic disease in the big picture of regulatory T cells. J. Allergy Clin. Immunol. 123(4), 735-746 (2009).
14. Akdis M, Akdis CA. Mechanisms of allergen-specifc immunotherapy. J. Allergy Clin. Immunol. 119(4), 780-791 (2007).
15. Novak N, Haberstok J, Bieber T, Allam JP. The immune privilege of the oral mucosa. Trends Mol. Med. 14(5), 191-198 (2008).
16. Pfaar O, Klimek L. Effcacy and safety of specifc immunotherapy with a high-dose sublingual grass pollen preparation: a double-blind, placebo-controlled trial. Ann. Allergy Asthma Immunol. 100(3), 256-263 (2008). (Pubitemid 351398005)
17. Bousquet J, Van Cauwenberge P, Khaltaev N; Aria Workshop Group; WHO. Allergic rhinitis and its impact on asthma. J. Allergy Clin. Immunol. 108(5 Suppl.), 147-343 (2001).
18. Rhodes BJ. Patient dropouts before completion of optimal dose, multiple allergen immunotherapy. Ann. Allergy Asthma Immunol. 82(3), 281-286 (1999).
19. Passalacqua G, Musarra A, Pecora S et al. Quantitative assessment of the compliance with a once-daily sublingual immunotherapy regimen in real life (EASY Project: Evaluation of a Novel SLIT Formulation During a Year). J. Allergy Clin. Immunol. 117(4), 946-948 (2006).
20. Blazowski L. Anaphylactic shock because of sublingual immunotherapy overdose during third year of maintenance dose. Allergy 63(3), 374 (2008). (Pubitemid 351224673)
21. Bernstein DI, Wanner M, Borish L, Liss GM. Immunotherapy committee, American academy of allergy, asthma and immunology. twelve-year survey of fatal reactions to allergen injections and skin testing: 1990-2001. J. Allergy Clin. Immunol. 113(6), 1129-1136 (2004).
22. Applegate LA, Ley RD, Alcalay J, Kripke ML. Identifcation of the molecular target for the suppression of contact hypersensitivity by ultraviolet radiation. J. Exp. Med. 170(4), 1117-1131 (1989). (Pubitemid 19250683)
23. Martínez-Gómez JM, Johansen P, Erdmann I, Senti G, Crameri R, Kündig TM. Intralymphatic injections as a new administration route for allergen-specifc immunotherapy. Int. Arch. Allergy Immunol. 150(1), 59-65 (2009).
24. Roelandts R. The history of phototherapy: something new under the sun? J. Am. Acad. Dermatol. 46(6), 926-930 (2002).
25. Zanolli M. The modern paradigm of phototherapy. Clin. Dermatol. 21(5), 398-406 (2003). (Pubitemid 37543556)
26. Beissert S, Schwarz T Role of immunomodulation in diseases responsive to phototherapy. Methods 28(1), 138-144 (2002).
27. Novák Z, Bérces A, Rontó G, Pállinger E, Dobozy A, Kemény L. Effcacy of different UV-emitting light sources in the induction of T-cell apoptosis. Photochem. Photobiol. 79(5), 434-439 (2004).
28. Matz H. UV light and its interaction with cutaneous receptors. Dermatol. Clin. 25(4), 633-641 (2007). (Pubitemid 47446079)
29. Toews GB, Bergstresser PR, Streilein JW. Epidermal Langerhans cell density determines whether contact hypersensitivity or unresponsiveness follows skin painting with DNFB. J. Immunol. 124(1), 445-453 (1980).
30. Weiss JM, Renkl AC, Denfeld RW et al. Low-dose UVB radiation perturbs the functional expression of B7.1 and B7.2 co-stimulatory molecules on human Langerhans cells. Eur. J. Immunol 25(10), 2858-2862 (1995).
31. Schwarz T, Urbanska A, Gschnait F, Luger TA. Inhibition of the induction of contact hypersensitivity by a UV-mediated epidermal cytokine. J. Invest. Dermatol. 87(2), 289-291 (1986). (Pubitemid 16041746)
32. Shreedhar V, Giese T, Sung VW, Ullrich SE. A cytokine cascade including prostaglandin E2, IL-4, and IL-10 is responsible for UV-induced systemic immune suppression. J. Immunol. 160(8), 3783-3789 (1998). (Pubitemid 28176081)
33. Csoma Z, Ignacz F, Bor Z et al. Intranasal irradiation with the xenon chloride ultraviolet B laser improves allergic rhinitis. J. Photochem. Photobiol. B. 75(3), 137-144 (2004). (Pubitemid 39194116)
34. Koreck A, Csoma Z, Boros-Gyevi M et al. Inhibition of immediate type hypersensitivity reaction by combined irradiation with ultraviolet and visible light. J. Photochem. Photobiol. B. 77(1-3), 93-96 (2004). (Pubitemid 39497252)
35. Koreck AI, Csoma Z, Bodai L et al Rhinophototherapy: a new therapeutic tool for the management of allergic rhinitis. J. Allergy Clin. Immunol. 115(3), 541-547 (2005). (Pubitemid 40341708)
36. Robert F. Shine on allergic rhinitis with rhinophototherapy. Family Prac. News 34(9), 39 (2004).
37. Koreck A, Csoma Zs, Kenderessy Szabó A et al. Rhinophototherapy improves allergic rhinitis by inducing apoptosis in T cells and eosinophils and inhibiting histamine release from mast cells. Presented at: XXIII. EAACI Congress. Amsterdam, The Netherlands, 12-16 June 2004.
38. Assenova K, Stoyanov S, Zlatanov H. Phototherapy for allergic rhinitis-our experience. GMS Curr. Posters Otorhinolaryngol. Head Neck Surg DOI:10.3205/09hnod323 (2009) (Epub ahead of print).
39. Boros-Gyevi M, Garaczi E, Koreck A, Széll M, Kemény L. Studies on the role of tumor necrosis factor a gene polymorphisms in the therapeutic response to intranasal UV phototherapy. WAO J. DOI: 10.1097/01. WOX.0000301194.09767.b9 (2007) (Epub ahead of print). (Pubitemid 46597679)
40. Koreck A, Csoma Zs, Boros-Gyevi M, Kemény L. Intranasal phototherapy is more effective than fexofenadine hydrochloride in the treatment of seasonal allergic rhinitis. Clin. Immunol. 115(Suppl. 1), 50 (2005).
41. Bella Z, Kadocsa E, Szekely L, Jori J. Rhinophototherapy in grass pollen induced allergic rhinitis. WAO J. DOI: 10.1097/01. WOX.0000301345.36484.e0 (2007) (Epub ahead of print). (Pubitemid 46597679)
42. Cingi C, Yaz A, Cakli H, Ozudogru E, Kecik C, Bal C. The effects of phototherapy on quality of life in allergic rhinitis cases. Eur. Arch. Otorhinolaryngol 266(12), 1903-1908 (2009).
43. Juniper EF, Guyatt GH. Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitis. Clin. Exp. Allergy 21(1), 77-83 (1991).
44. Koreck A, Szechenyi A, Morocz M et al Effects of intranasal phototherapy on nasal mucosa in patients with allergic rhinitis. J. Photochem. Photobiol. B. 89(2-3), 163-169 (2007). (Pubitemid 350154473)
45. Mitchell D, Paniker L, Sanchez G et al Molecular response of nasal mucosa to therapeutic exposure to broad-band ultraviolet radiation. J. Cell. Mol. Med. DOI: 10.1111/j.1582-4934.2008.00442.x (2008) (Epub ahead of print).
46. Fornace AJ Jr, Lechner JF, Grafstrom RC, Harris CC. DNA repair in human bronchial epithelial cells. Carcinogenesis 3(12), 1373-1377(1982). (Pubitemid 13183468)
47. Lee E, Koo J, Berger T UVB phototherapy and skin cancer risk: a review of the literature. Int. J. Dermatol. 44(5), 355-360 (2005). (Pubitemid 40691978)
48. Hearn RM, Kerr AC, Rahim KF, Ferguson J, Dawe RS. Incidence of skin cancers in 3867 patients treated with narrow-band ultraviolet B phototherapy. Br. J. Dermatol 159(4), 931-935 (2008).
49. Godar DE. UV doses worldwide. Photochem. Photobiol. 81(4), 736-749 (2005).